For example, the previous literature also estimated the difference in DNA methylation levels at the CpG site in TXNIP in patients with controlled and poorly controlled T2DM compared to with individuals free of diagnosed T2DM [9]. The gene discussed is TXNIP; the disease is type 2 diabetes mellitus.